| Chief Investigator |
School |
Project |
Total funding |
| Dr Elena Bagley |
School of Medical Sciences |
Endogenous opioids in the amygdala. |
$365,223 |
| Professor Bernard Balleine |
School of Medical Sciences |
Pathological habits and the amygdala |
$416,962 |
| Dr Linda Bendall |
Western Clinical School |
Increasing sensitivity tochemotherapy by disrupting leukemic cell interactions with the bone marrow |
$649,658 |
| Associate Professor David Booth |
Western Clinical School |
How do the Vitamin D Receptor activation genes CYP27B1 and CYP24A1 alter susceptibility to autoimmune diseases |
$491,897 |
| Professor Warwick Britton |
Central Clinical School |
Improving subunit vaccines against tuberculosis for pulmonary delivery |
$615,221 |
| Dr Daniel Brown |
Central Clinical School |
Investigation into the Physiological Mechanism Underlying Vertigo Attacks in Meniere's Disease |
$302,742 |
| Dr Anthony Cesare |
Children's Medical Research Institute |
How cells with damaged telomeres make an orderly exit from the cell proliferation cycle |
$292,181 |
| Dr Clara Chow |
The George Institute for Global Health |
TEXTMEDS |
$1,360,167 |
| Dr Sandra Cooper |
Children's Hospital Westmead Clinical School |
Dysferlin mediates membrane repair for skeletal and cardiac injury |
$755,955 |
| Professor Jonathan Craig |
School of Public Health |
ARDAC Third Phase Study |
$1,816,455 |
| Professor Anthony Cunningham |
Western Clinical School |
Herpes simplex virus immunity in skin |
$504,552 |
| Dr Guangda Feng |
Central Clinical School |
Dissecting in vivo cellular response to interferons in pathogen-infected host |
$463,139 |
| Professor Barbara Fazekas de St Groth |
Central Clinical School |
Dendritic cell-mediated induction of T cell tolerance |
$632,128 |
| Dr Yuanyuan Ge |
Central Clinical School |
Cancer radiotherapy 2020: accounting for tumour deformation in real time to improve treatment accuracy |
$358,795 |
| Professor Jacob George |
Western Clinical School |
Hepatitis C related Liver Disease |
$487,847 |
| Professor Jacob George |
Western Clinical School |
Adiponectin and cholesterol a driving force in NASH immunopathogenesis |
$420,498 |
| Professor Grantley Gill |
School of Public Health |
SNAC1: A randomised trial of sentinel node based management versus axillary clearance for women with small breast cancers |
$366,663 |
| Professor Mark Gillies |
Central Clinical School |
The contribution of aberrant Wnt signalling to neuronal and vascular pathology in retinal disease |
$541,967 |
| Associate Professor Ulrike Grunert |
Central Clinical School |
Microcircuits in primate retina |
$508,283 |
| Associate Professor Adam Guastella |
School of Medical Sciences |
Oxytocin and treatment for todllers with Autism |
$494,012 |
| Professor David Handelsman |
Concord Clinical School |
Ultrasensitive LC-MS Estradiol Assay |
$234,201 |
| Professor David Harris |
Western Clinical School |
Beta-catenin in profibrotic and anti-inflammatory effects of TGF-Beta |
$572,643 |
| Associate Professor Beric Henderson |
Western Clinical School |
Novel mechanisms of beta-catenin nuclear import in cancer |
$469,484 |
| Associate Professor Jonathan Iredell |
Western Clinical School |
POC |
$372,619 |
| Associate Professor Jonathan Iredell |
Western Clinical School |
Ecological effects of antibiotics |
$702,992 |
| Dr Christopher Jolly |
Central Clinical School |
Role of uracil-DNA glycosylases in oncogenic translocation |
$495,295 |
| Dr Danuta Kalinowski |
School of Medical Sciences |
Implementing Albumin as a Pharmacological Carrier of Novel Iron Chelators |
$541,472 |
| Dr Masaomi Kato |
Central Clinical School |
MicroRNA-Mediated Genetic Regulation of Ageing |
$553,143 |
| Dr Lisa Keay |
Central Clinical School |
Understanding the impact of cataract vision impairment on risk of falling |
$775,262 |
| Professor Anthony Keech |
School of Public Health |
Unlocking genetic and epigenetic factors in predicting vascular complications in Type 2 diabetes |
$1,071,754 |
| Associate Professor Marina Kennerson |
Concord Clinical School |
Finding Genes for Charcot-Marie Tooth (CMT) Neuropathy |
$585,347 |
| Associate Professor Trevor Leong |
School of Public Health |
The TOPGEAR trial; trial of preoperative therapy for gastric and esophagogastric junction adenocarcinoma |
$1,974,558 |
| Dr Chung-Wei Christine Lin |
The George Institute for Global Health |
PRECISE: pregabalin in addition to usual care for sciatica |
$618,589 |
| Professor Richard Lindley |
The George Institute for Global Health |
The ATTEND Trial |
$1,533,894 |
| Associate Professor Christopher Little |
Northern Clinical School |
Inflammation and osteoarthritis |
$632,128 |
| Professor Guy Marks |
Central Clinical School |
Community-wide active case finding for tuberculosis |
$3,422,325 |
| Associate Professor Peter Meikle |
School of Public Health |
Predicting Response to Fenofibrate Treatment in Type 2 Diabetes - Peter Meikle |
$621,134 |
| Dr Linda Mileshkin |
School of Public Health |
The OUTBACK trial - the role of adjuvant chemotherapy in locally advanced cervical cancer |
$1,472,782 |
| Dr Natasha Nassar |
Northern Clinical School |
Prenatal origins and outcomes of male reproductive disorders |
$226,943 |
| Dr Natasha Nassar |
Northern Clinical School |
Infant thyroid hormone levels and long-term child health and school achievement |
$476,257 |
| Professor Bruce Neal |
The George Institute for Global Health |
A randomised trial to determine the effects of salt reduction on vascular disease |
$3,410,985 |
| Associate Professor David Peiris |
The George Institute for Global Health |
The PEACH Study |
$1,852,716 |
| Associate Professor Vlado Perkovic |
The George Institute for Global Health |
The SIGNAL Trial: Steroids in ImmunoGlobulin A Nephropathy: Assessment of long term outcomes |
$2,681,619 |
| Professor Roger Reddel |
Children's Medical Research Institute |
Control of cell proliferation by sudden telomere shortening |
$389,681 |
| Professor Roger Reddel |
Children's Medical Research Institute |
A new method used by cancer cells to escape the normal limits on proliferation |
$546,347 |
| Professor Phillip Robinson |
Children's Medical Research Institute |
The role of a botulinum toxin protein receptor in neurotranmission |
$592,143 |
| Dr Renae Ryan |
School of Medical Sciences |
The structural basis for glutamate transporter function |
$360,431 |
| Professor Christopher Semsarian |
Central Clinical School |
Neuro-Cardiac Genetic Basis of Sudden Unexpected Death in Epilepsy |
$555,431 |
| Professor Christopher Semsarian |
Central Clinical School |
New Gene Discovery in Familial Hypertrophic Cardiomyopathy |
$404,050 |
| Associate Professor Vitali Sintchenko |
Western Clinical School |
Towards TB elimination in Australia |
$772,199 |
| Professor Tania Sorrell |
Western Clinical School |
Macrophages in the pathogenesis of cryptococcal meningoencephalitis |
$567,768 |
| Professor Graeme Stewart |
Western Clinical School |
Clinical significance of IL7R genotype |
$606,768 |
| Professor Roland Stocker |
School of Medical Sciences |
Why and how a heme-degrading enzyme protects |
$666,587 |
| Professor William Tarnow-Mordi |
School of Public Health |
The Lactoferrin Infant Feeding Trial (LIFT) |
$2,203,171 |
| Professor Martin Tattersall |
Central Clinical School |
Advance care planning in incurable cancer patients with disease progression on first line chemotherapy: a randomised trial |
$745,946 |
| Associate Professor Liza Thomas |
Western Clinical School |
Chemotherapy and cardiotoxicity |
$260,102 |
| Associate Professor James Triccas |
Central Clinical School |
New vaccines to prevent tuberculosis |
$573,628 |
| Professor Merrilyn Walton |
School of Public Health |
An investigation of the patient experience of adverse events |
$587,543 |
| Dr David Wang |
Central Clinical School |
The effect of morphine on obstructive sleep apnea |
$515,779 |
| Professor Karen Waters |
Children's Hospital Westmead Clinical School |
Does treatment of OSA improve IQ in preschool children? |
$990,144 |
| Professor Wolfgang Weninger |
Central Clinical School |
Age-dependent regulation of type 2 immunity by dermal innate lymphoid cells |
$588,253 |
| Dr Nicholas Wood |
Children's Hospital Westmead Clinical School |
Febrile seizures following vaccination in children: How common are they and what is the long term clinical outcome? |
$672,385 |
| Dr Nicholas Wood |
Children's Hospital Westmead Clinical School |
Q fever: How common is it and how can we best prevent it? Research to inform Q fever vaccine policy in Australia and Internationally |
$721,151 |